In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy.
Petrone L, Petruccioli E, Alonzi T, Vanini V, Cuzzi G, Najafi Fard S, Castilletti C, Palmieri F, Gualano G, Vittozzi P, Nicastri E, Lepore L, Grifoni A, Antinori A, Vergori A, Ippolito G, Cantini F, Goletti D.
Petrone L, et al. Among authors: petruccioli e.
J Infect. 2021 Apr;82(4):58-66. doi: 10.1016/j.jinf.2021.02.023. Epub 2021 Feb 25.
J Infect. 2021.
PMID: 33639176
Free PMC article.